| 1 | 1st to market products | | | | | | | 2 | 0.85% |
| 2 | about us overview mission | | | | | | | 1 | 0.43% |
| 3 | present innovative solutions learn | | | | | | | 1 | 0.43% |
| 4 | treatment of patients we | | | | | | | 1 | 0.43% |
| 5 | of patients we clearly | | | | | | | 1 | 0.43% |
| 6 | understand our customers’ needs | | | | | | | 1 | 0.43% |
| 7 | our customers’ needs and | | | | | | | 1 | 0.43% |
| 8 | customers’ needs and use | | | | | | | 1 | 0.43% |
| 9 | needs and use cuttingedge | | | | | | | 1 | 0.43% |
| 10 | and use cuttingedge technology | | | | | | | 1 | 0.43% |
| 11 | use cuttingedge technology to | | | | | | | 1 | 0.43% |
| 12 | innovative solutions learn more | | | | | | | 1 | 0.43% |
| 13 | segments for treatment of | | | | | | | 1 | 0.43% |
| 14 | solutions learn more researchdevelopment | | | | | | | 1 | 0.43% |
| 15 | learn more researchdevelopment the | | | | | | | 1 | 0.43% |
| 16 | innovation edge ajanta’s rd | | | | | | | 1 | 0.43% |
| 17 | edge ajanta’s rd has | | | | | | | 1 | 0.43% |
| 18 | ajanta’s rd has been | | | | | | | 1 | 0.43% |
| 19 | rd has been consistently | | | | | | | 1 | 0.43% |
| 20 | has been consistently developing | | | | | | | 1 | 0.43% |
| 21 | difficult and complex products | | | | | | | 1 | 0.43% |
| 22 | and complex products to | | | | | | | 1 | 0.43% |
| 23 | for treatment of patients | | | | | | | 1 | 0.43% |
| 24 | therapeutic segments for treatment | | | | | | | 1 | 0.43% |
| 25 | products to harness patient | | | | | | | 1 | 0.43% |
| 26 | market products learn more | | | | | | | 1 | 0.43% |
| 27 | world we enjoy leadership | | | | | | | 1 | 0.43% |
| 28 | we enjoy leadership in | | | | | | | 1 | 0.43% |
| 29 | enjoy leadership in multiple | | | | | | | 1 | 0.43% |
| 30 | leadership in multiple molecules | | | | | | | 1 | 0.43% |
| 31 | in multiple molecules and | | | | | | | 1 | 0.43% |
| 32 | therapeutic segments through 1st | | | | | | | 1 | 0.43% |
| 33 | segments through 1st to | | | | | | | 1 | 0.43% |
| 34 | through 1st to market | | | | | | | 1 | 0.43% |
| 35 | to market products learn | | | | | | | 1 | 0.43% |
| 36 | business areas differentiatedsmart product | | | | | | | 1 | 0.43% |
| 37 | different therapeutic segments for | | | | | | | 1 | 0.43% |
| 38 | areas differentiatedsmart product portfolio | | | | | | | 1 | 0.43% |
| 39 | differentiatedsmart product portfolio at | | | | | | | 1 | 0.43% |
| 40 | us overview mission and | | | | | | | 1 | 0.43% |